Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
24.91
-0.39 (-1.54%)
At close: Mar 28, 2025, 4:00 PM
24.43
-0.48 (-1.93%)
After-hours: Mar 28, 2025, 4:54 PM EDT

Pacira BioSciences Revenue

In the year 2024, Pacira BioSciences had annual revenue of $700.97M with 3.85% growth. Pacira BioSciences had revenue of $187.25M in the quarter ending December 31, 2024, with 3.32% growth.

Revenue (ttm)
$700.97M
Revenue Growth
+3.85%
P/S Ratio
1.64
Revenue / Employee
$887,299
Employees
790
Market Cap
1.15B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024700.97M25.99M3.85%
Dec 31, 2023674.98M8.16M1.22%
Dec 31, 2022666.82M125.29M23.14%
Dec 31, 2021541.53M111.89M26.04%
Dec 31, 2020429.65M8.62M2.05%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.